Discusses the importance and prevalence of deoxyribonucleic acid (DNA) hypermethylation in cancer. Potential value of hypomethylating agents in the treatment of human neoplasms; Aberrant CpG island methylation in cancer; Rationale for use of methylation inhibitors in neoplasia; Chemical structure and mechanisms of action of hypomethylating agents.